Therefore, we extended the scope of evaluation indexes (PASI, DLQI, PDI were used) and performed subgroup analysis, and also introduced the association marker CRP, in order to evaluate and validate the efficacy and safety of oral vitamin D supplementation in the treatment of psoriasis from more perspectives. Here, CRP is linked to psoriasis.